Epoprostenol Sodium: Medgend

Epoprostenol Sodium FDA Approved Drugs

EPOPROSTENOL SODIUM [Epoprostenol Sodium^{C₂₀H₃₁O₅Na}]

eq 0.5mg base/vial (injection injectable)

eq 1.5mg base/vial (injection injectable)

Teva Pharms Usa^{Apr 23, 2008}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

FLOLAN [Epoprostenol Sodium^{C₂₀H₃₁O₅Na}]

eq 0.5mg base/vial (injection injectable)

eq 1.5mg base/vial (injection injectable)

Glaxosmithkline Llc^{Sep 20, 1995}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

REMODULIN [Treprostinil^{C₂₃H₃₄O₅}]

10mg/ml (iv (infusion), subcutaneous injectable)

1mg/ml (iv (infusion), subcutaneous injectable)

2.5mg/ml (iv (infusion), subcutaneous injectable)

United Therap^{May 21, 2002}

Administration of remodulin diluted for intravenous infusion with sterile diluent for flolan or sterile diluent for epoprostenol sodium prior to administration.
Administration of remodulin diluted for intravenous infusion with sterile water for injection or 0.9% sodium chloride injection prior to administration.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

VELETRI [Epoprostenol Sodium^{C₂₀H₃₁O₅Na}]

eq 0.5mg base/vial (injection injectable)

eq 1.5mg base/vial (injection injectable)

Actelion Pharms Ltd^{Jun 28, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.